U.S. Hemp Roundtable Responds to Recent Federal Legislation
The U.S. Hemp Roundtable, a coalition that advocates for science‑based hemp regulation, has issued a detailed update to its members after Congress passed language that would effectively ban the majority of hemp‑derived products. While the measure poses a significant challenge, the group emphasizes that a 365‑day window now exists to work with federal regulators on a framework that protects consumers without imposing an outright prohibition.
Legislative Setback and Its Immediate Impact
The continuing resolution that reopened the federal government included a provision restricting the sale of any hemp extract containing more than 0.4 milligrams of total THC per container. According to the Roundtable’s analysis, this threshold would exclude more than 95 % of the hemp extract products currently on the market. Only a small subset of low‑potency items—often specialty tinctures or capsules—would remain legally sellable under the new rule.
Industry Reaction and the 365‑Day Window
Roundtable leaders expressed disappointment but noted that the legislation delays enforcement until November 13, 2026. This one‑year period provides an opportunity for the industry to educate policymakers, demonstrate existing self‑regulatory practices, and propose constructive alternatives to a blanket ban. The group frames the coming months as “365 days to regulate, not ban.”
Root Causes: Misinformation and Political Dynamics
Several senators who supported the language were told the amendment would safeguard non‑intoxicating CBD products, a claim the Roundtable says is inaccurate because the majority of CBD items sold nationwide exceed the 0.4 mg THC limit per container. Proponents also argued the measure would curb fully synthetic THC and copycat products marketed to minors. Critics warn that, without a regulated pathway, such products could migrate to illicit markets, undermining consumer safety.
Additionally, some legislators cited concerns over a prolonged government shutdown as a factor in their decision, suggesting that the urgency to reopen offices influenced votes on the hemp provision.
Path Forward: Proposed Regulatory Bills
In response, the Roundtable is backing legislative efforts that would replace the ban with a comprehensive regulatory scheme. Representative Morgan Griffith (R‑VA), chairman of the House Energy and Commerce Health Subcommittee, is expected to introduce a bill that would:
- Require good manufacturing practices (GMP) for all hemp processors;
- Mandate accurate labeling of cannabinoid content;
- Prohibit synthetic THC analogues;
- Implement strong age‑verification and marketing restrictions to keep products away from children.
In the Senate, Senators Ron Wyden (D‑OR) and Jeff Merkley (D‑OR) are preparing to reintroduce their own regulatory bill for review by the Health, Education, Labor, and Pensions (HELP) committee. Both proposals aim to establish clear federal oversight while preserving access to hemp‑derived wellness products.
Voices from the Roundtable
Art Massolo, president of the U.S. Hemp Roundtable and vice president of business development at Cycling Frog, said:
“Businesses are deeply disappointed by the decisions of Congress and their openness to receiving false information so easily. The next year will be critical in determining the future of hemp. As a significant American industry, we are committed to sharing with Congress the real story about hemp. Because the truth is that good actors in the industry have created a self‑regulation authority to protect consumers. But we need Congress’ help to keep the bad actors out. Hemp is here to stay – let’s do it right.”
Ken Meyer, co‑owner of Complete Hemp Processing and co‑chair of the Roundtable’s Farmer Advisory Council, highlighted the sector’s resilience:
“American farmers have proven to be resilient, and hemp is no different. The 2018 Farm Bill gave us a chance to embrace innovation and invest in a profitable crop. Our focus now is education of Congress and building a path that secures hemp for future generations and keeps farmers in business.”
Jonathan Miller, general counsel for the U.S. Hemp Roundtable, added:
“The U.S. Hemp Roundtable is eager for the year ahead and the opportunity to right the course for the industry. The support of Senator Rand Paul has afforded our industry the opportunity to ensure our products are around for the seniors that struggle with pain or the veterans that battle anxiety and PTSD. We are grateful for leaders that understand the true value of hemp and who will continue to advocate for responsible regulations that protect consumers and a uniquely American industry.”
About the U.S. Hemp Roundtable
The U.S. Hemp Roundtable is a coalition of dozens of leading companies and organizations dedicated to advancing safe hemp and CBD products. Representing major national grassroots groups, the Roundtable works through education, advocacy, and collaboration with policymakers to foster a regulatory environment that protects consumers while supporting a lawful, innovative hemp industry.
Source: Here
